Score Breakdown
Trash.
NuScale Power is a speculative pre-revenue nuclear technology company trading at $3.7B market cap (~117x TTM sales of $31.5M) with no binding commercial contracts, 75%+ annual dilution, coordinated C-suite insider selling, a $495M milestone payment to an unproven partner triggered by a non-binding agreement, and revenue almost entirely from a related party (Fluor) that is aggressively exiting its position. While the NRC design certification is a genuine first-mover advantage in SMR technology, the path from regulatory approval to commercial deployment spans 5+ years and requires billions in customer-funded construction. The current valuation prices in extraordinary success with near-zero probability of failure, yet the company has already cancelled its flagship CFPP project, faces class-action lawsuits over ENTRA1 misrepresentations, and is burning ~$200M+ annually with no clear inflection point. The 28% short interest reflects legitimate fundamental concerns. At current share counts (~164M shares, heading toward 300M+ with Fluor conversions and ATM sales), the per-share value destruction from dilution alone makes this an extremely poor risk/reward even if the technology eventually succeeds commercially.
Negative cash flow. Can't value it.
Major red flags in SEC filings.
Shares melting fast.
No data.
Tight but ok.
Heavy bearish bets.
Incompetent.
🐻 Why Bears Hate It
The primary bear thesis centers on the lack of binding 'hard' contracts despite years of development, compounded by a massive $495 million milestone payment to partner ENTRA1 in Q3 2025 that led to a quarterly loss of $532 million. Critics argue the business model relies on expensive, unproven partnerships and that the earliest operational timeline for reactors (early 2030s) is too distant to justify current valuations. The short case is further bolstered by the cancellation of the Carbon Free Power Project (CFPP) and ongoing equity dilution from at-the-market (ATM) offerings.
🔍 What's In The SEC Filings
The company is undergoing massive structural dilution and has committed to nearly $500M in milestone payments triggered by non-binding agreements, while the entire C-suite has simultaneously established significant exit plans.
Aggressive expansion of authorized share capital and massive secondary sales.
“Fluor has agreed to... vote all the shares of the Class A common stock that Fluor then owns in favor of any proposal to amend the Company’s Certificate of Incorporation, as amended, to increase the number of authorized shares up to 662 million.”
The company is seeking to more than double its current share count, having already used ATM programs to sell $577.6M in shares during 2025, while Fluor is set to convert 110.9M Class B units into Class A common stock.
Coordinated C-suite 10b5-1 adoption for significant share liquidations.
“the Company’s chief executive officer, John Hopkins, adopted a plan on September 10, 2025... and provides for the aggregate purchase or sale of 1,132,701 shares.”
In a single 37-day window (August-September 2025), the CEO, CFO, CTO, CCO, COO, and VP of Delivery all adopted 10b5-1 plans, signaling a collective lack of confidence or a coordinated exit strategy.
Extreme revenue concentration with a related party.
“For the three and nine months ended September 30, 2025, Fluor accounted for 96% and 76%, respectively, of total revenue.”
Nearly all recognized revenue is derived from the company's largest shareholder (Fluor), suggesting a lack of independent commercial viability for the SMR technology in the open market.
Massive liability/expense recognition based on non-binding agreements.
“As of September 30, 2025, the criteria for triggering payment of Milestone Contribution 1 has been achieved, as ENTRA1 has entered into a non-binding agreement relating to 72 NPMs.”
NuScale recognized a $495M G&A expense and a $346.5M liability for payments to ENTRA1 simply because ENTRA1 signed a non-binding term sheet, effectively converting 'intent' into a massive financial obligation.
The intrinsic value per share is being aggressively destroyed by dilution; the move to increase authorized shares to 662 million suggests current prices are viewed as an opportunity to issue massive amounts of equity to fund the $551.8M in outstanding contractual commitments.
The implied Tax Receivable Agreement (TRA) obligation surged from $63.3M to $250.8M in nine months. While not recorded on the balance sheet because it is not deemed 'probable,' it represents a massive potential drain on future cash flows if the company ever achieves profitability.